For the quarter ending 2025-09-30, PASG has $74,160K in assets. $43,040K in debts. $52,773K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 52,773 | 57,626 | ||
| Marketable securities | - | 0 | ||
| Prepaid expenses and other current assets | 1,637 | 1,402 | ||
| Prepaid research and development | 1,320 | 1,287 | ||
| Total current assets | 55,730 | 60,315 | ||
| Property and equipment, net | 5,159 | 5,340 | ||
| Right of use assets - operating leases | 13,001 | 13,273 | ||
| Other assets | 270 | 270 | ||
| Total assets | 74,160 | 79,198 | ||
| Accounts payable | 952 | 2,395 | ||
| Accrued expenses and other current liabilities | 4,001 | 4,073 | ||
| Non-refundable sublicense and transition services payments | 13,750 | 9,741 | ||
| Operating lease liabilities | 3,542 | 3,592 | ||
| Total current liabilities | 22,245 | 19,801 | ||
| Operating lease liabilities - noncurrent | 20,795 | 21,139 | ||
| Total liabilities | 43,040 | 40,940 | ||
| Additional paidin capital | 722,894 | 722,283 | ||
| Accumulated deficit | -691,774 | -684,025 | ||
| Total stockholders' equity | 31,120 | 38,258 | ||
| Total liabilities and stockholders' equity | 74,160 | 79,198 | ||
Passage BIO, Inc. (PASG)
Passage BIO, Inc. (PASG)